RevvityRVTY
NYSE · USA · Segment 5 of 8 in the Medicine, pharma & life science value chain: Life science tools
Life science tools and diagnostics across newborn screening and research.
Life science tools: Instruments, reagents and equipment for research, development and production.
Key metrics
Market cap
$12.6B
Price
$112.72
Today
−0.2%
Return YTD
+16.7%
Return 1Y
+12.8%
P/E
52.4
P/S
4.3
P/B
1.7
Data as of 2026-07-10 · updates daily after U.S. close
Theme exposure
In the value chain
Products & services
- Newborn & genetic screening
- Research reagents
- Laboratory software
Competitors
Risks
- Research budgets
- Post-divestiture integration
Same segment: Life science tools
See where Revvity sits in the full Medicine, pharma & life science map — every segment from upstream suppliers to end markets, with daily metrics.Open the Life science value chain →